Skip to main content

podcasts | GileadPro

Referring Patients for CAR T-cell therapy

In this series of podcasts healthcare professionals discuss key considerations to support better understanding of
communication needs when referring patients for CAR T-cell therapy.


Printable summaries of the podcasts are also available to download.

HIVdigtital hörbar Dr.med. Thomas Buhk

Patient communication and CAR T-cell therapy

Discussing patient communication and sharing their experiences are Dr Wendy Osbourne, Consultant Haematologist specialising in Lymphoma at Newcastle Upon Tyne Hospitals NHS Foundation and Surabhi Chaturvedi, Senior Psychotherapist and Service Lead, Haemato-Oncology Psychosocial Support Team at Kings College Hospital in London.

Podcast recorded June 2025.
Full length: 27:22 minutes

00:00 / 27:22

HIVdigtital hörbar Dr.med. Thomas Buhk

The role of Clinical Nurse Specialists in patient communication and CAR T-cell therapy

Clinical nurse specialists (CNSs) are a key part of the communication journey for patients. Discussing the subject and sharing their experiences are CAR T CNSs, Emily John, Lead CAR T CNS at Cardiff and Cellular Therapy CNS with Anthony Nolan and Luminita Keating, Cellular Therapies CAR T CNS at Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust.

Podcast recorded June 2025.
Full length: 18:31 minutes

00:00 / 18:21

Stay up to date

Receive email updates from Gilead, including promotional communications.


UKI-YES-0526 April 2026

Adverse events should be reported.

For the UK, reporting forms and information can be found at www.mhra.gov.uk/yellowcard or via the Yellow Card app (download from the Apple App Store or Google Play Store). For IE, reporting forms and information can be found at www.hpra.ie and can be reported to HPRA on +353 1 6764971. Adverse events should also be reported to Gilead to [email protected] or +44(0) 1223 897500 or +353(0) 21 482 5999.